Correlation Between Theseus Pharmaceuticals and ABVC Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Theseus Pharmaceuticals and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Theseus Pharmaceuticals and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Theseus Pharmaceuticals and ABVC Biopharma, you can compare the effects of market volatilities on Theseus Pharmaceuticals and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Theseus Pharmaceuticals with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Theseus Pharmaceuticals and ABVC Biopharma.

Diversification Opportunities for Theseus Pharmaceuticals and ABVC Biopharma

TheseusABVCDiversified AwayTheseusABVCDiversified Away100%
0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Theseus and ABVC is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Theseus Pharmaceuticals and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Theseus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Theseus Pharmaceuticals are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Theseus Pharmaceuticals i.e., Theseus Pharmaceuticals and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Theseus Pharmaceuticals and ABVC Biopharma

If you would invest (100.00) in Theseus Pharmaceuticals on December 12, 2024 and sell it today you would earn a total of  100.00  from holding Theseus Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Theseus Pharmaceuticals  vs.  ABVC Biopharma

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -20-1001020304050
JavaScript chart by amCharts 3.21.15THRX ABVC
       Timeline  
Theseus Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Theseus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Theseus Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
ABVC Biopharma 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ABVC Biopharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, ABVC Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar0.40.50.60.70.8

Theseus Pharmaceuticals and ABVC Biopharma Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15 0.0020.0040.0060.0080.0100.012
JavaScript chart by amCharts 3.21.15THRX ABVC
       Returns  

Pair Trading with Theseus Pharmaceuticals and ABVC Biopharma

The main advantage of trading using opposite Theseus Pharmaceuticals and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Theseus Pharmaceuticals position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.
The idea behind Theseus Pharmaceuticals and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stocks Directory
Find actively traded stocks across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas